Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
November 2025: Boehringer Ingelheim licensed a novel GLP-1 analogue candidate from a research partner to advance its pipeline for type 2 diabetes and obesity indications
Effective and safe
Homocysteine and hypomethylation
If you experience any suspected side effects from a medicine including medicines obtained in a trial report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
GLP-1s work by mimicking the naturally occurring hormone GLP-1, which helps your body regulate blood sugar, helps you know when you are full, and slows the movement of food from your stomach to your small intestine
Its designed to help people with type 2 diabetes manage their blood sugar levels, and its also been making waves in the weight loss community for its effectiveness in curbing appetite
US$ 27.00
US$ 25.88
US$ 23.59
US$ 23.51
US$ 27.85
US$ 27.30
US$ 28.15
US$ 20.76
